Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386217 · ClinicalTrials.gov registry record
Psychosocial Impact of Cancer-Related Female Infertility
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 239
- Enrollment target
NCT00386217: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00386217 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 239 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00386217 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 239 participants
- Enrollment target
Study Summary
The success of cancer treatment combined with the trend to delay childbearing is increasing the numbers of women survivors whose childbearing has been interrupted by cancer. For some, treatment has resulted in infertility. Others have been advised to delay pregnancy until a certain follow-up interval or have new fears that pregnancy could be a risk to maternal health. Not least is the concern that children born after a mother's cancer would face increased risks for birth defects or cancer. The specific aims of this project are as follows: 1. To measure the impact of cancer-related interruption of childbearing on women's long-term emotional well-being and health-related quality of life, over and above other demographic and cancer-related factors 2. To find out if becoming a biological or social mother after cancer treatment decreases the long-term psychosocial impact of interrupted childbearing compared to remaining childless 3. To refine the psychometric properties of questionnaires for female cancer survivors measuring Distress about Cancer-Related Childbearing Issues and Attitudes towards Parenthood after Cancer 4. To define targets for a future intervention to improve female survivors' knowledge about childbearing after cancer, decrease distress associated with interrupted childbearing, and promote peer support.
Interventions
- BEHAVIORAL Telephone Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2004-12 |
| Est. Completion | 2008-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00386217
The ClinicalTrials.gov registry entry for NCT00386217 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telephone Survey is the first listed.
NCT00386217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00386217 about?
NCT00386217 is a clinical study titled "Psychosocial Impact of Cancer-Related Female Infertility". The success of cancer treatment combined with the trend to delay childbearing is increasing the numbers of women survivors whose childbearing has been interrupted by cancer. For some, treatment has resulted in infertility. Others have been advised to delay pregnancy until a certain follow-up interva...
What is the current status of trial NCT00386217?
This trial is currently completed. The enrollment target is 239 participants. The study started on 2004-12. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00386217?
The interventions under investigation include: Telephone Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT00386217?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.